BNTC
Benitec Biopharma Inc. · NASDAQ · Healthcare · USD · 10-K for 2026, filed 2026-09-14
Figures on this page computed 2026-11-08 12:40 UTC
Last close
9.54USD
Market data, 2026-11-06
Except where said otherwise: 10-K for 2026, filed 2026-09-14
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001193125-26-390570
- Reported in
- USD
- computed
- 10-K for 2026, filed 2026-09-14
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001193125-26-390570
- Reported in
- USD
- 10-K for 2026, filed 2026-09-14
- 10-K for 2026, filed 2026-09-14
- 10-K for 2026, filed 2026-09-14
- 10-K for 2026, filed 2026-09-14
- 10-K for 2026, filed 2026-09-14
- 10-K for 2026, filed 2026-09-14
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001193125-26-390570
- Reported in
- USD
- 10-K for 2026, filed 2026-09-14
- 10-K for 2026, filed 2026-09-14
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001193125-26-390570
- Reported in
- USD
- 10-K for 2026, filed 2026-09-14
- 10-K for 2026, filed 2026-09-14
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001193125-26-390570
- Reported in
- USD
- 10-K for 2026, filed 2026-09-14
- 10-K for 2026, filed 2026-09-14
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Growth is the furthest below its sector's middle: 0.35 against 0.46 on the market's range.
- Growth-20.1%35 of 100, below its sector
- Returns on capital-25.7%24 of 100, above its sector
- Marginsn/anot placed
- Price2.5x37 of 100, below its sector
- Safety34.0099 of 100, above its sector
- What it pays outn/anot placed
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
What it sells, to whom
lens 8 of 9Where it sells it
1Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.
0 segments, 1 places and 0 named customers, each as the filer published it.
0 segments, 1 places and 0 named customers, each as the filer published it.
Every figure in this lens
AUSTRALIA14,627,00010-K for 2019, filed 2020-09-23
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2019
- Accession
- 0001193125-20-252381
- Reported in
- AUD